Measuring Brain Tumor Consistency Using Magnetic Resonance Elastography

Brain Neoplasm Clinical Trial

Official title: Measuring Brain Tumor Consistency Using Magnetic Resonance Elastography

Status Not yet recruiting

Clinical Trial Summary

This clinical trial tests whether a new imaging technique called magnetic resonance elastography (MRE) is useful in determining the consistency of brain tumors and whether this could be used to guide surgical planning and choice of approach (the type of surgery that is needed) for patients with brain tumors. Comparing MRE with the typical magnetic resonance imaging (MRI) scan may help researchers assess the quality, reliability, and diagnostic utility of this scan when evaluating brain tumors.

Clinical Trial Description

PRIMARY OBJECTIVES:

I. Examine tolerance interval of MRE measurement in kilopascals (kPa) and associated distribution of percent stiff (hard) and soft tumors above the higher limit and below the lower limit.

II. Through machine learning with MRE and clinical/demographic factors, to identify diagnostic thresholds in separating stiff tumor from soft tumor.

OUTLINE:

Patients undergo MRE scan over 25 minutes before surgery at the time of standard of care pre-operative MRI scan. On the day of surgery, the surgeon grades and records tumor consistency/stiffness during the operation and afterwards. ;

Related Conditions & MeSH terms

• Brain Neoplasm
• Brain Neoplasms

• NCT number: NCT05516485
• Study type: Interventional
• Source: University of Southern California
• Contact: Janet Jaime
• Phone: 323-865-3205
• Email: Janet.jaime@med.usc.edu
• Status: Not yet recruiting
• Phase: N/A
• Start date: July 1, 2024
• Completion date: July 1, 2028